These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32462203)

  • 1. Gypenosides Protect Orbital Fibroblasts in Graves Ophthalmopathy via Anti-Inflammation and Anti-Fibrosis Effects.
    Li H; Ma C; Liu W; He J; Li K
    Invest Ophthalmol Vis Sci; 2020 May; 61(5):64. PubMed ID: 32462203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves' Ophthalmopathy by Targeting Orbital Fibroblasts.
    Yang S; Wang X; Xiao W; Xu Z; Ye H; Sha X; Yang H
    Front Endocrinol (Lausanne); 2022; 13():891922. PubMed ID: 35663306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Effect of Gypenosides on Antioxidant Stress Injury in Orbital Fibroblasts of Graves' Orbitopathy.
    Ma C; Li H; Liu W; Lu S; Li X; Chen J; Li K; Wang W
    J Immunol Res; 2022; 2022():4432584. PubMed ID: 36157877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an
    Wang X; Yang S; Ye H; Chen J; Shi L; Feng L; Wang X; Zhang T; Chen R; Xiao W; Yang H
    Thyroid; 2022 Mar; 32(3):294-305. PubMed ID: 34605662
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.
    Kim JA; Ahn D; Kim BY; Choi YJ; Shin HJ; Jang SY
    Br J Ophthalmol; 2021 Feb; 105(2):290-296. PubMed ID: 31488432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy.
    Fang S; Huang Y; Zhong S; Li Y; Zhang Y; Li Y; Sun J; Liu X; Wang Y; Zhang S; Xu T; Sun X; Gu P; Li D; Zhou H; Li B; Fan X
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4273-4283. PubMed ID: 28938397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yes-Associated Protein Mediates the Transition from Inflammation to Fibrosis in Graves' Orbitopathy.
    Ko J; Kim YJ; Choi SH; Lee CS; Yoon JS
    Thyroid; 2023 Dec; 33(12):1465-1475. PubMed ID: 37800725
    [No Abstract]   [Full Text] [Related]  

  • 8. Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy.
    Xiong H; Wu M; Zou H; Jiang S; Yi H; Yi T; Wang Q; Liu D; Zhou Y; Wei C; Zhou X
    Mol Vis; 2018; 24():509-517. PubMed ID: 30090014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of Graves' orbitopathy.
    Yoon JS; Chae MK; Jang SY; Lee SY; Lee EJ
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5921-9. PubMed ID: 22871832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts.
    Diao J; Chen X; Mou P; Ma X; Wei R
    Invest Ophthalmol Vis Sci; 2022 Sep; 63(10):6. PubMed ID: 36094643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for Graves' orbitopathy.
    Cao J; Qi X; Wang N; Chen Y; Xie B; Ma C; Chen Z; Xiong W
    J Endocrinol Invest; 2023 Oct; 46(10):2005-2016. PubMed ID: 36849849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M1-Like Macrophages Modulate Fibrosis and Inflammation of Orbital Fibroblasts in Graves' Orbitopathy: Potential Relevance to Soluble Interleukin-6 Receptor.
    Lu Y; Wang Y; Wang Y; Wu Y; Huang Y; Liu X; Zhang S; Zhong S; Li Y; Li B; Sun J; Fang S; Zhou H
    Thyroid; 2023 Mar; 33(3):338-350. PubMed ID: 36617890
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves' orbitopathy.
    Jang SY; Choi SH; Kikkawa D; Lee EJ; Yoon JS
    PLoS One; 2021; 16(8):e0255344. PubMed ID: 34383782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antifibrotic effect of pirfenidone on orbital fibroblasts in patients with thyroid-associated ophthalmopathy and its mechanisms].
    Li DD; Liu Y; Yuan RR; Yu T; Yang B; Pang WY
    Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):185-190. PubMed ID: 30803176
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy.
    Jang SY; Park SJ; Chae MK; Lee JH; Lee EJ; Yoon JS
    Br J Ophthalmol; 2018 Mar; 102(3):407-414. PubMed ID: 29101123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lutein targeting orbital fibroblasts attenuates fibrotic and inflammatory effects in thyroid-associated ophthalmopathy.
    Hei X; Lin B; Wu P; Li X; Mao Z; Huang S; Zhang F; Zhou M; Ke Y; Yang H; Huang D
    Exp Eye Res; 2023 Jul; 232():109515. PubMed ID: 37207866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential Role of Osteopontin in the Pathogenesis of Graves' Ophthalmopathy.
    Lou H; Wu LQ; Wang H; Wei RL; Cheng JW
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):18. PubMed ID: 34546326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Therapeutic Role of Bone Morphogenic Protein 7 (BMP7) in the Pathogenesis of Graves' Orbitopathy.
    Kim BY; Choi SH; Kim JY; Ko J; Yook JI; Kim HS; Lee EJ; Kikkawa DO; Yoon JS
    Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):7. PubMed ID: 35671049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
    Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y
    J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tea Polyphenols Reduce Inflammation of Orbital Fibroblasts in Graves' Ophthalmopathy via the NF-κB/NLRP3 Pathway.
    Liu W; Ma C; Li HY; Yuan SS; Li KJ
    Curr Med Sci; 2023 Feb; 43(1):123-129. PubMed ID: 36821039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.